These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 32851922)

  • 1. Refractory Hypertension and Risks of Adverse Cardiovascular Events and Mortality in Patients With Resistant Hypertension: A Prospective Cohort Study.
    Cardoso CRL; Salles GF
    J Am Heart Assoc; 2020 Sep; 9(17):e017634. PubMed ID: 32851922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic Importance of On-Treatment Clinic and Ambulatory Blood Pressures in Resistant Hypertension: A Cohort Study.
    Cardoso CRL; Salles GC; Salles GF
    Hypertension; 2020 May; 75(5):1184-1194. PubMed ID: 32200673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic impact of clinic and ambulatory blood pressure components in high-risk type 2 diabetic patients: the Rio de Janeiro Type 2 Diabetes Cohort Study.
    Salles GF; Leite NC; Pereira BB; Nascimento EM; Cardoso CR
    J Hypertens; 2013 Nov; 31(11):2176-86. PubMed ID: 24029864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Resistant hypertension and the risk of major adverse cardiac and cerebrovascular events in outpatients].
    Xia JH; Wang XY; Kang YY; Huang JF; Guo QH; Cheng YB; Li Y; Wang JG
    Zhonghua Xin Xue Guan Bing Za Zhi; 2024 Aug; 52(8):884-891. PubMed ID: 39143779
    [No Abstract]   [Full Text] [Related]  

  • 5. Refractory Hypertension: a Narrative Systematic Review with Emphasis on Prognosis.
    Bacan G; Ribeiro-Silva A; Oliveira VAS; Cardoso CRL; Salles GF
    Curr Hypertens Rep; 2022 Apr; 24(4):95-106. PubMed ID: 35107787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic Impact of On-Treatment Cumulative Ambulatory Blood Pressures for Adverse Macro- and Microvascular Outcomes in Individuals With Type 2 Diabetes: The Rio de Janeiro Type 2 Diabetes Cohort.
    Cardoso CRL; Leite NC; Salles GF
    Hypertension; 2023 Oct; 80(10):2178-2186. PubMed ID: 37548035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic Effect of the Nocturnal Blood Pressure Fall in Hypertensive Patients: The Ambulatory Blood Pressure Collaboration in Patients With Hypertension (ABC-H) Meta-Analysis.
    Salles GF; Reboldi G; Fagard RH; Cardoso CR; Pierdomenico SD; Verdecchia P; Eguchi K; Kario K; Hoshide S; Polonia J; de la Sierra A; Hermida RC; Dolan E; O'Brien E; Roush GC;
    Hypertension; 2016 Apr; 67(4):693-700. PubMed ID: 26902495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic influence of office and ambulatory blood pressures in resistant hypertension.
    Salles GF; Cardoso CR; Muxfeldt ES
    Arch Intern Med; 2008 Nov; 168(21):2340-6. PubMed ID: 19029499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and prognosis of refractory hypertension diagnosed using ambulatory blood pressure measurements.
    Yoon M; You SC; Oh J; Lee CJ; Lee SH; Kang SM; Park S
    Hypertens Res; 2022 Aug; 45(8):1353-1362. PubMed ID: 35027714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic Importance of Resistant Hypertension in Patients With Type 2 Diabetes: The Rio de Janeiro Type 2 Diabetes Cohort Study.
    Cardoso CRL; Leite NC; Bacan G; Ataíde DS; Gorgonio LKC; Salles GF
    Diabetes Care; 2020 Jan; 43(1):219-227. PubMed ID: 31619394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sleep-time blood pressure: prognostic value and relevance as a therapeutic target for cardiovascular risk reduction.
    Hermida RC; Ayala DE; Fernández JR; Mojón A
    Chronobiol Int; 2013 Mar; 30(1-2):68-86. PubMed ID: 23181592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Home-measured blood pressure is a stronger predictor of cardiovascular risk than office blood pressure: the Finn-Home study.
    Niiranen TJ; Hänninen MR; Johansson J; Reunanen A; Jula AM
    Hypertension; 2010 Jun; 55(6):1346-51. PubMed ID: 20385970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and clinical characteristics of isolated-office and true resistant hypertension determined by ambulatory blood pressure monitoring.
    Ríos MT; Domínguez-Sardiña M; Ayala DE; Gomara S; Sineiro E; Pousa L; Callejas PA; Fontao MJ; Fernández JR; Hermida RC;
    Chronobiol Int; 2013 Mar; 30(1-2):207-20. PubMed ID: 23077975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between Clinic and Ambulatory Blood-Pressure Measurements and Mortality.
    Banegas JR; Ruilope LM; de la Sierra A; Vinyoles E; Gorostidi M; de la Cruz JJ; Ruiz-Hurtado G; Segura J; Rodríguez-Artalejo F; Williams B
    N Engl J Med; 2018 Apr; 378(16):1509-1520. PubMed ID: 29669232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular outcome in treated hypertensive patients with responder, masked, false resistant, and true resistant hypertension.
    Pierdomenico SD; Lapenna D; Bucci A; Di Tommaso R; Di Mascio R; Manente BM; Caldarella MP; Neri M; Cuccurullo F; Mezzetti A
    Am J Hypertens; 2005 Nov; 18(11):1422-8. PubMed ID: 16280275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blunted sleep-time relative blood pressure decline increases cardiovascular risk independent of blood pressure level--the "normotensive non-dipper" paradox.
    Hermida RC; Ayala DE; Mojón A; Fernández JR
    Chronobiol Int; 2013 Mar; 30(1-2):87-98. PubMed ID: 23039824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antihypertensive Medication Adherence and Confirmation of True Refractory Hypertension.
    Siddiqui M; Judd EK; Dudenbostel T; Gupta P; Tomaszewski M; Patel P; Oparil S; Calhoun DA
    Hypertension; 2020 Feb; 75(2):510-515. PubMed ID: 31813346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Night-day blood pressure ratio and dipping pattern as predictors of death and cardiovascular events in hypertension.
    Fagard RH; Thijs L; Staessen JA; Clement DL; De Buyzere ML; De Bacquer DA
    J Hum Hypertens; 2009 Oct; 23(10):645-53. PubMed ID: 19225527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Invasively Measured Aortic Systolic Blood Pressure and Office Systolic Blood Pressure in Cardiovascular Risk Assessment: A Prospective Cohort Study.
    Laugesen E; Knudsen ST; Hansen KW; Rossen NB; Jensen LO; Hansen MG; Munkholm H; Thomsen KK; Søndergaard H; Bøttcher M; Raungaard B; Madsen M; Hulman A; Witte D; Bøtker HE; Poulsen PL
    Hypertension; 2016 Sep; 68(3):768-74. PubMed ID: 27402917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No evidence for a J-shaped curve in treated hypertensive patients with increased cardiovascular risk: The VALUE trial.
    Kjeldsen SE; Berge E; Bangalore S; Messerli FH; Mancia G; Holzhauer B; Hua TA; Zappe D; Zanchetti A; Weber MA; Julius S
    Blood Press; 2016; 25(2):83-92. PubMed ID: 26511535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.